Blood test can predict presence of beta-amyloid in the brain, new …
Feb 17, 2022 · A new blood test that predicts amyloid plaques in the brain shows promise as a cost-effective, noninvasive alternative to brain imaging and spinal tap tests, an NIA-funded study finds.
New Treatment Reverses Alzheimer’s Disease Signs
Dec 20, 2023 · Both early-life and middle-age treatment showed signs of inhibiting the process that forms the most prominent protein aggregates in Alzheimer’s, known as amyloid beta plaques. For the later treatment, not only the underlying process but also the amyloid plaque numbers themselves were reduced.
Alzheimer's: Boosting brain protein may slow cognitive decline
Sep 18, 2024 · New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting brain protein amounts may offer cognitive benefits.
A new kind of blood test can detect signs of Alzheimer’s with ...
Aug 1, 2024 · New blood tests are set to change how Alzheimer's is diagnosed and treated by offering an easy way to see if patients have amyloid plaques and tau tangles in their brains — hallmarks of the...
Amyloid is everywhere, but new treatments could stop the toxic
2 days ago · Amyloid deposits are present in the brains of cognitively impaired individuals, but also accumulate throughout the body. ... news. article. Amyloid is everywhere, but new treatments could stop the ...
UC study: Alzheimer’s drug may work by boosting brain protein …
Sep 11, 2024 · Recently, several new monoclonal antibody medications designed to remove amyloid from the brain were approved after showing they lessened cognitive decline in clinical trials. Espay and his colleagues noticed that these drugs unintentionally increased levels of Aβ42.
The Amyloid-β Pathway in Alzheimer’s Disease
Aug 30, 2021 · Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the center of Alzheimer’s disease (AD) pathophysiology.
In breakthrough Alzheimer’s discovery, Emory research team finds …
Aug 12, 2024 · In a paper published August 9 in Cell Reports Medicine, Todd E. Golde and Yona Levites explain how the amyloid beta deposits long known to build up in the brains of Alzheimer’s patients serve as a kind of scaffold for the accumulation of other proteins.
Critical assessment of anti-amyloid-β monoclonal antibodies …
Oct 28, 2024 · The amyloid hypothesis postulates that deposition of amyloid-beta (Aβ) pathology in the brain drives tau pathology, neurodegeneration, and ultimately cognitive decline in Alzheimer’s disease ...
Takeda and AC Immune Announce Exclusive Option and License …
May 13, 2024 · Takeda and AC Immune partner for ACI-24.060, an active immunotherapy targeting toxic forms of amyloid beta to potentially slow Alzheimer’s disease progression. Learn more about this groundbreaking treatment approach and …